Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia

被引:46
作者
Woods, CW
Bressler, AM
LiPuma, JJ
Alexander, BD
Clements, DA
Weber, DJ
Moore, CM
Reller, LB
Kaye, KS
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Sch Med, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Clin Microbiol Lab, Durham, NC USA
[5] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA
[6] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA
关键词
D O I
10.1086/383313
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Burkholderia cepacia complex includes 9 genomovars. The relative virulence of each is unknown. Host and pathogen features associated with mortality were evaluated among patients with B. cepacia complex bacteremia. Cases were ascertained through review of blood culture results for the period of May 1996 through May 2002. Isolates were identified to species level with 16S rDNA and recA-based species-specific polymerase chain reaction analyses and recA restriction fragment - length polymorphism. Strain typing was performed with pulsed-field gel electrophoresis. Fifty-three patients with B. cepacia complex bacteremia were identified; only 9 (17%) had cystic fibrosis. Twenty-five patients (47%) died within 14 days of bacteremia. After controlling for comorbid conditions and therapeutic interventions, 2 outbreak-related strains of Burkholderia cenocepacia (genomovar III) were associated with 14-day mortality ( odds ratio, 5.5; 95% confidence interval, 1.20 - 25.02). B. cenocepacia is an emerging nosocomial pathogen. Certain strains are associated with an enhanced capacity for interpatient spread and poor outcome.
引用
收藏
页码:1243 / 1250
页数:8
相关论文
共 35 条
  • [1] Burkholderia cepacia complex infection in Italian patients with cystic fibrosis:: Prevalence, epidemiology, and genomovar status
    Agodi, A
    Mahenthiralingam, E
    Barchitta, M
    Gianninò, V
    Sciacca, A
    Stefani, S
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (08) : 2891 - 2896
  • [2] Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex -: Survival linked to genomovar type
    Aris, RM
    Routh, JC
    LiPuma, JJ
    Heath, DG
    Gilligan, PH
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (11) : 2102 - 2106
  • [3] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [4] BURKHOLDER WH, 1950, PHYTOPATHOLOGY, V40, P115
  • [5] Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III
    Coenye, T
    Spilker, T
    Martin, A
    LiPuma, JJ
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (09) : 3300 - 3307
  • [6] Taxonomy and identification of the Burkholderia cepacia complex
    Coenye, T
    Vandamme, P
    Govan, JRW
    Lipuma, JJ
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (10) : 3427 - 3436
  • [7] Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis
    De Soyza, A
    McDowell, A
    Archer, L
    Dark, JH
    Elborn, SJ
    Mahenthiralingam, E
    Gould, K
    Corris, PA
    [J]. LANCET, 2001, 358 (9295) : 1780 - 1781
  • [8] CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988
    GARNER, JS
    JARVIS, WR
    EMORI, TG
    HORAN, TC
    HUGHES, JM
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) : 128 - 140
  • [9] Searching for an improved clinical comorbidity index for use with ICD-9-CM administrative data
    Ghali, WA
    Hall, RE
    Rosen, AK
    Ash, AS
    Moskowitz, MA
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (03) : 273 - 278
  • [10] GravelTopper D, 1996, INFECT CONT HOSP EP, V17, P737